New York City filed a suit naming nearly every U.S. pharmaceutical manufacturer, accusing them of overcharging the Medicaid program through fraud and unfair and deceptive trade practices. The suit, brought against 44 companies and their subsidiaries, is the largest of several suits brought recently by states and cities making similar charges in an attempt to reclaim some of estimated tens of millions of dollars they believe were charged to the program beyond what the cost should have been. A spokesperson for the pharmaceutical industry did not comment on the lawsuit, but argued drug costs only represent one-sixth of total Medicaid expenses.

Full Story:

Related Summaries